Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls

European Urology

Volumn 70, Issue 6, 2016, Pages 941-951

  Price, Alison J ^a,b   Travis, Ruth C ^a   Appleby, Paul N ^a   Albanes, Demetrius ^c   Barricarte Gurrea, Aurelio ^d,e,f   Bjørge, Tone ^g,h   Bueno de Mesquita, H Bas ^i,j,k,l   Chen, Chu ^m   Donovan, Jenny ⁿ   Gislefoss, Randi ^h,ac   Goodman, Gary ^m   Gunter, Marc ^k   Hamdy, Freddie C ^a   Johansson, Mattias ^o,p   King, Irena B ^q   Kühn, Tilman ^r   Männistö, Satu ^s   Martin, Richard M ^n,t,u   Meyer, Klaus ^v   Neal, David E ^w   Neuhouser, Marian L ^m   Nygård, Ottar ^g,x   Stattin, Par ^p   Tell, Grethe S ^g   Trichopoulou, Antonia ^y,z   Tumino, Rosario ^aa   Ueland, Per Magne ^g   Ulvik, Arve ^v   de Vogel, Stefan ^g   Vollset, Stein Emil ^g,ab   Weinstein, Stephanie J ^c   Key, Timothy J ^a   Allen, Naomi E ^ad   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e IdiSNA Navarra Institute for Health Research   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF BERGEN   (Norway)

^h CANCER REGISTRY OF NORWAY   (Norway)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l UNIVERSITY OF MALAYA   (Malaysia)

^m USA   (United States)

ⁿ UNIVERSITY OF BRISTOL   (United Kingdom)

^o INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^p UMEÅ UNIVERSITY   (Sweden)

^q UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^r GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^s NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^t UNIVERSITY OF BRISTOL   (United Kingdom)

^u The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^v BEVITAL AS   (Norway)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^x HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^y UNIVERSITY OF ATHENS   (Greece)

^z HELLENIC HEALTH FOUNDATION   (Greece)

^aa CIVILE M P AREZZO HOSPITAL   (Italy)

^ab NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^ac Institute of Population based Cancer Research   (Norway)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Folate; High grade; Pooled data meta analysis; Prospective cohort; Prostate cancer; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HEXETIDINE;

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLIC ACID BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; VITAMIN BLOOD LEVEL; AGED; BLOOD; COHORT ANALYSIS; MIDDLE AGED; ODDS RATIO; PROSTATE TUMOR; RISK; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FOLIC ACID; HEXETIDINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; RISK; VITAMIN B 12;

EID: 84962476764     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.03.029     Document Type: Article

References (36)

1. [1] Fenech, M., Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat Res 733 (2012), 21–33.
2. [2] Blount, B.C., Mack, M.M., Wehr, C.M., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997), 3290–3295.
3. [3] Collin, S.M., Metcalfe, C., Refsum, H., et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 19 (2010), 1632–1642.
4. [4] Etzioni, R., Cha, R., Feuer, E.J., Davidov, O., Asymptomatic incidence and duration of prostate cancer. Am J Epidem 148 (1998), 775–785.
5. [5] Breslow, N., Chan, C.W., Dhom, G., Latent carcinoma of prostate at autopsy in seven areas. Int J Cancer 20 (1977), 680–688.
6. [6] Stattin, P., Holmberg, E., Johansson, J.E., Holmberg, L., Adolfsson, J., Hugosson, J., National Prostate Cancer Register (NPCR) of Sweden. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst 102 (2010), 950–958.
7. [7] Platz, E.A., De Marzo, A.M., Giovannucci, E., Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem 91 (2004), 553–571.
8. 12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 113 (2005), 819–824.
9. 12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev 17 (2008), 279–285.
10. 12, and homocysteine. Cancer Epidemiol Biomarkers Prev 12 (2003), 1271–1272.
11. [11] Beilby, J., Ambrosini, G.L., Rossi, E., De Klerk, N.H., Musk, A.W., Serum levels of folate, lycopene, B-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 64 (2010), 1235–1238.
12. 12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. Int J Epidemiol 42 (2013), 201–210.
13. [13] Omenn, G.S., Goodman, G., Thornquist, M., et al. The ß-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 54:Suppl (1994), 2038s–2043s.
14. [14] Finne, P., Fallah, M., Hakama, M., et al. Lead-time in the European randomised study of screening for prostate cancer. Eur J Cancer 46 (2010), 3102–3108.
15. [15] Vollset, S.E., Clarke, R., Lewington, S., et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50 000 individuals. Lancet 381 (2013), 1029–1036.
16. [16] Petersen, L.F., Brockton, N.T., Bakkar, A., et al. Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells. BJU Int 109 (2012), 788–795.
17. [17] Bistulfi, G., Foster, B.A., Karasik, E., et al. Dietary folate deficiency blocks prostate cancer progression in the TRAMP model. Cancer Prev Res 4 (2011), 1825–1834.
18. [18] Tomaszewski, J.J., Cummings, J.L., Parwani, A.V., et al. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 71 (2011), 1287–1293.
19. [19] Guo, S., Jiang, X., Chen, X., Chen, L., Li, X., Jia, Y., The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: evidence from 23 case-control studies. Gene 565 (2015), 90–95.
20. [20] Tomaszewski, J.J., Richman, E.L., Sadetsky, N., et al. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol 191 (2014), 971–976.
21. [21] Kasperzyk, J.L., Fall, K., Mucci, L.A., et al. One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr 90 (2009), 561–569.
22. [22] Etzioni, R., Penson, D.F., Legler, J.M., et al. Over diagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94 (2002), 981–990.
23. [23] Melia, J., Moss, S., Johns, L., Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 94 (2004), 51–56.
24. [24] Cope, E.L., Shrubsole, M.J., Cohen, S.S., et al. Intra-individual variation in one-carbon metabolism plasma biomarkers. Cancer Epidemiol Biomarkers Prev 22 (2013), 1894–1899.
25. [25] Leenders, M., Ros, M.M., Sluijs, I., et al. Reliability of selected antioxidants and compounds involved in one-carbon metabolism in two dutch cohorts. Nutr Cancer 65 (2013), 17–24.
26. [26] Midttun, Ø., Townsend, M.K., Nygård, O., et al. Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. J Nutr 144 (2014), 784–790.
27. [27] Pfeiffer, C.M., Hughes, J.P., Lacher, D.A., et al. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010. J Nutr 142 (2012), 886–893.
28. [28] Lawrence, M.A., Chai, W., Kara, R., Rosenberg, I.H., Scott, J., Tedstone, A., Examination of selected national policies towards mandatory folic acid fortification. Nutr Rev 67:Suppl 1 (2009), S73–S78.
29. [29] Park, J.Y., Nicolas, G., Freisling, H., et al. Comparison of standardised dietary folate intake across ten countries participating in the European prospective investigation into cancer and nutrition. Br J Nutr 108 (2012), 552–569.
30. [30] Drammeh, B.S., Schleicher, R.L., Pfeiffer, C.M., Jain, R.B., Zhang, M., Phuong, H.N., Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem 54 (2008), 1883–1891.
31. [31] Van Eijsden, M., Van Der Wal, M.F., Hornstra, G., Bonsel, G.J., Can whole-blood samples be stored over 24 hours without compromising stability of C-reactive protein, retinol, ferritin, folic acid, and fatty acids in epidemiologic research?. Clin Chem 51 (2005), 230–232.
32. [32] Chu, S.Y., MacLeod, J., Effect of three-day clot contact on results of common biochemical tests with serum. Clin Chem, 32, 1986, 2100.
33. [33] Zhang, D.J., Elswick, R.K., Miller, W.G., Bailey, J.L., Effect of serum-clot contact time on clinical chemistry laboratory results. Clin Chem 44 (1998), 1325–1333.
34. [34] Hustad, S., Eussen, S., Midttun, Ø., et al. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 58 (2012), 402–410.
35. [35] Hannisdal, R., Svardal, A., Ueland, P.M., Measurement of folate in fresh and archival serum samples as p-aminobenzoylglutamate equivalents. Clin Chem 54 (2008), 665–672.
36. [36] Hannisda, R., Gislefoss, R.E., Grimsrud, T.K., Hustad, S., Mørkrid, L., Ueland, P.M., Analytical recovery of folate and its degradation products in human serum stored at -25 °C for up to 29 years. J Nutr 140 (2010), 522–526.